Field dossier · from the corpus
Genetic enhancement
0predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gene therapy comes of age
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Viral vector platforms within the gene therapy landscape
Drug delivery systems for RNA therapeutics
Delivering CRISPR: a review of the challenges and approaches
Recent work · 2024 onward
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Exagamglogene Autotemcel for Severe Sickle Cell Disease
Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy
Adeno-Associated Virus Engineering and Load Strategy for Tropism Modification, Immune Evasion and Enhanced Transgene Expression
Complement System Response to Adeno-Associated Virus Vector Gene Therapy
Clinical Application of Adenovirus (AdV): A Comprehensive Review